Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1838]

Neoadjuvant and adjuvant therapy in triple negative breast cancer

Prof Banu Arun - MD Anderson Center, Houston, USA

Neoadjuvant and adjuvant therapy in triple negative breast cancer ( Prof Banu Arun - MD Anderson Center, Houston, USA )

Breast cancer in young women from Asia

Dr Wu Jiong - Fudan University, Shanghai, China

Breast cancer in young women from Asia ( Dr Wu Jiong - Fudan University, Shanghai, China )

Specialising in breast cancer surgery

Prof Riccardo Audisio - University of Liverpool, Liverpool, UK

Specialising in breast cancer surgery ( Prof Riccardo Audisio - University of Liverpool, Liverpool, UK )

Expert insight: Managing neutropenia in breast cancer patients

Dr Matti Aapro and Prof Hope Rugo

Expert insight: Managing neutropenia in breast cancer patients ( Dr Matti Aapro and Prof Hope Rugo )

SABCS 2017: The latest in CDK inhibition in breast cancer

Prof Nadia Harbeck, Dr Mark Beresford, Dr Shom Goel and Dr Sara Hurvitz

SABCS 2017: The latest in CDK inhibition in breast cancer ( Prof Nadia Harbeck, Dr Mark Beresford, Dr Shom Goel and Dr Sara Hurvitz )

Circulating tumour cells may predict late recurrence in HR-positive breast...

Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA

Circulating tumour cells may predict late recurrence in HR-positive breast cancer patients ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )

Postmenopausal women who lose weight may have reduced breast cancer risk

Prof Rowan Chlebowski - City of Hope, Duarte, USA

Postmenopausal women who lose weight may have reduced breast cancer risk ( Prof Rowan Chlebowski - City of Hope, Duarte, USA )

Talazoparib vs physicians choice for patients with mBRCA1 breast cancer

Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA

Talazoparib vs physicians choice for patients with mBRCA1 breast cancer ( Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA )

CDK 4/6 inhibitors for older women with HR-positive breast cancer

Harpreet Singh - FDA, USA

CDK 4/6 inhibitors for older women with HR-positive breast cancer ( Harpreet Singh - FDA, USA )

Reducing risk of breast cancer recurrence and death with increased dose density

Prof Richard Gray - University of Oxford, Oxford, UK

Reducing risk of breast cancer recurrence and death with increased dose density ( Prof Richard Gray - University of Oxford, Oxford, UK )

Breast cancer therapy resistance mediated by FGFR amplification

Dr Luigi Formisano - Vanderbilt University Medical Center, Nashville, USA

Breast cancer therapy resistance mediated by FGFR amplification ( Dr Luigi Formisano - Vanderbilt University Medical Center, Nashville, USA )

The significance of CEACAM 5 in metastases of triple negative breast cancer

Emily Powell - MD Anderson Cancer Center, Houston, USA

The significance of CEACAM 5 in metastases of triple negative breast cancer ( Emily Powell - MD Anderson Cancer Center, Houston, USA )

More from ecancer